Research
ELRIG Advances in Cell-based Screening 2026
The pharmaceutical industry is poised for a paradigm shift: moving away from animal models prior to human trials. This conference unites leaders from pharma, academia, and the exhibitor ecosystem to address the critical question: What is needed to engineer the post-animal drug discovery...
ELRIG Announces Prof Hazel Screen and Dr Dave Powell as Keynote Speakers for Advances in Cell-based Screening 2026
• Free-to-attend conference takes place at AstraZeneca in Gothenburg, Sweden from 6–7 May • Programme to focus on advancement of animal-replacement technologies and transition towards human-first, AI-driven drug discovery ...
The CCDC’s GOLD Proven Docking and Virtual Screening Software Integrated with the New Sigmatic Sciences Life Science AI Platform
Sigmatic Sciences Launches SigmaticOS – The Only Complete Lab-in-the-Loop Platform for All ScientistsSigmatic Sciences, a Sapio Sciences company, enables scientists to move from copilot to autopilot with true lab-in-the-loop automation with integrated model training.SigmaticOS is the on...
Cyber Threat Workshop
Free workshop hosted by Norfolk & Suffolk Police Force at The EpiCentre. Discover practical steps to protect yourself and your business ...
Quantum computing: The future of healthcare in the UK?
Dr Chaitanya Erady takes us through quantum computing’s potential to solve complex biological mysteries, the reality of near-term hybrid systems, and how healthcare must prepare. ...
Abselion establishes US subsidiary in Cambridge, MA
Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform ...
When platforms step back: what Unity’s “soft decoupling” signals for UK–EU–China life sciences
Unity’s recent decision to delist China-based developers from its global Asset Store, alongside reports that the company may explore selling its China business, has prompted strong reactions across the technology sector. At first glance, this appears to be a story about the gaming indus...
ON Helix 2026 - Disrupting Bio Innovation
In the dynamic landscape of improving patient outcomes, Disrupting Bio Innovation refers to the breakthrough technologies, policies and business models that are shaping the drug discovery and development landscape. Don’t miss this opportunity to connect with the pioneers ...
From Cohorts to Clinical Insights: Multimodal AI research at Korea’s National Institute of Health
This seminar introduces KNIH’s recent AI research initiatives and highlights key outcomes across multiple domains. ...
Drop-in clinic - Copywriting Advice with Emveria Creations
Len Keenan from Emveria Creations helps start-up businesses explain their innovations to investors and partners in a language they understand. While helping more established businesses fine-tune their messaging. ...